Collaborations
INEX and Alnylam ink research collaboration for systemic delivery of RNAi therapeutics
Published in Gene Therapy Weekly, April 27th, 2006
The work with Alnylam on the encapsulation and delivery of RNAi therapeutics builds on INEX's expertise in the delivery of oligonucleotides under its Targeted Immunotherapy platform.
The collaboration will evaluate multiple targets including apolipoprotein B (apoB), a protein involved in cholesterol metabolism. The INEX and Alnylam agreement will build on preliminary data published by Alnylam...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-04-27)
More Articles from Gene Therapy Weekly
- Antisense Technology
Retinal ganglion cell transfection is achieved by retrograde transfer of antisense oligonucleotides - Gene Silencing
Gene silencing of HIV chemokine receptors is achieved using ribozymes and antisense RNA - Gene Transfection
siRNA or siLNA transfection fails to induce anti-viral responses in HeLa and MCF cells - Lung Cancer
Lung adenocarcinoma invasion and metastasis is suppressed by contactin knockdown - Retinitis Pigmentosa
Retinal rds-peripherin is suppressed by RNAi and can be replaced - Antimicrobial Agents
Degenerate phosphorothioate oligonucleotides prevent prion conversion - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
